Brandon Capital is a leading venture capital firm based in Palo Alto, CA, specializing in investing in life science companies that focus on medical innovations. With a diverse portfolio of active investments spanning Australia, New Zealand, the United States, and the United Kingdom, Brandon Capital supports entrepreneurs from the early stages of development to commercialization, aiming to create value for teams, investors, and ultimately, patients.
Recognizing the importance of long-term partnerships, Brandon Capital acts as a founding investor for most of its current portfolio companies, which include cutting-edge biotech firms targeting neurodegenerative diseases, developing novel therapeutics for cancer and inflammatory diseases, and pioneering advancements in immuno-oncology and mitochondrial therapeutics.
Generated from the website